Home / Author Archives: Market Watch

Author Archives: Market Watch

ProQR shares rises on FDA orphan drug designation

Shares of ProQR Therapeutics rose 10% in premarket trading after it said the Food and Drug Administration had granted an orphan-drug designation to QR-1123. The experimental therapy is being tested as a treatment for vision loss caused by autosomal dominant ...

Read More »

La-Z-Boy shares sink 10% as tariffs take a toll

La-Z-Boy Inc. shares sank 10.2% in Thursday premarket trading after the furniture company reported an earnings miss, with tariffs taking a toll. La-Z-Boy’s Casegoods segment had a 6.3% sales decline to $29.4 million, which the company attributed to “industry challenges,” ...

Read More »